Cardiac MRI Characterizes a Comprehensive Range of Cardiomyopathies
Cardiac MRI can characterize virtually all major cardiomyopathy subtypes through its superior tissue characterization capabilities, including hypertrophic, dilated, restrictive, arrhythmogenic, non-compaction, stress-induced (Takotsubo), peripartum, muscular dystrophy-related, and infiltrative cardiomyopathies (amyloidosis, sarcoidosis, Anderson-Fabry disease, hemochromatosis). 1
Primary Cardiomyopathies Characterized by Cardiac MRI
Hypertrophic Cardiomyopathy (HCM)
- Morphological assessment: MRI excels at identifying all phenotypic variants (asymmetric septal, apical, mid-ventricular, lateral wall, mass-like, and concentric types) 1
- Superior visualization: Detects areas missed by echocardiography, particularly the LV apex, LV lateral wall, LV basal septum, and RV 1
- Late gadolinium enhancement (LGE): Present in 50-80% of HCM patients; extent >15% of LV mass predicts sudden cardiac death risk 1
- Distinguishes phenocopies: Differentiates true HCM from Anderson-Fabry disease (shows low native T1 values from sphingolipid deposition with basal inferolateral LGE), Danon disease, athlete's heart, and hypertensive heart disease 1
Dilated Cardiomyopathy (DCM)
- Functional quantification: Provides gold-standard measurements of LV/RV volumes, mass, and ejection fraction with high reproducibility 1, 2
- LGE patterns: Linear mid-myocardial or patchy patterns help distinguish etiology and predict malignant arrhythmia risk 1
- Parametric mapping: T1-mapping and extracellular volume (ECV) quantification detect early fibrosis and track therapeutic response 1
- Strain imaging: Detects regional dysfunction in early disease stages before overt heart failure 2
Restrictive Cardiomyopathies
Cardiac Amyloidosis:
- Characteristic finding: Early unusual contrast washout with subendocardial enhancement and non-suppressible remote myocardium signal 3
- Elevated ECV and T1 values: Quantifies amyloid burden
- Differentiates from constrictive pericarditis: Unlike constrictive pericarditis, amyloidosis shows normal pericardial thickness 3
Anderson-Fabry Disease:
- Pathognomonic feature: Low native T1 values (from sphingolipid deposition) before structural abnormalities develop 1
- LGE pattern: Mid-myocardial or subepicardial in basal inferolateral LV segment 1
Hemochromatosis:
- T2 mapping*: Detects and quantifies iron overload with high sensitivity 1
Sarcoidosis:
- Patchy mid-myocardial or subepicardial LGE: Indicates granulomatous inflammation
- T2-weighted imaging: Detects active myocardial edema 1
Arrhythmogenic Cardiomyopathy (AC)
- Structural abnormalities: Superior detection of RV wall thinning, aneurysms in the "triangle of dysplasia" (inferior, apical, infundibular walls) 4
- Fatty infiltration and fibrosis: Distinguishes pathological fatty replacement from normal epicardial fat 4
- LV involvement: Detects posterolateral LV involvement in >50% of cases, often missed by other modalities 4
- Quantitative parameters: RV volumes, ejection fraction, and regional wall motion abnormalities for diagnostic criteria 4
Left Ventricular Non-Compaction (LVNC)
- Diagnostic criteria: Non-compacted to compacted myocardial thickness ratio >2.3 in end-diastole 1
- Additional metrics: Trabecular mass >15 g/m², trabecular-to-total LV mass ratio >20-25% 1
- Prognostic value: Higher ratios and presence of LGE predict heart failure and arrhythmia development 1
- Caveat: 15-43% of asymptomatic healthy individuals meet current MRI criteria, suggesting poor specificity—may represent anatomical variant rather than true cardiomyopathy 1
Stress-Induced (Takotsubo) Cardiomyopathy
- Morphological pattern: LV apical ballooning with hyperkinetic basal segments (also reverse and mid-ventricular variants) 1
- Myocardial edema: High T2 signal, elevated native T1 and T2 values in affected segments 1
- LGE findings: Typically absent, but present in up to 40% with lower signal intensity (<5 SD above normal) indicating worse prognosis 1
- RV involvement: Detected in 40% of cases, associated with worse prognosis 1
Peripartum Cardiomyopathy
- Functional assessment: LV dilation, global LV systolic dysfunction, RV dysfunction 1
- LGE pattern: Subepicardial or mid-myocardial in anterior/anterolateral segments (40% of cases), more common >7 days post-acute phase 1
- Prognostic marker: Presence of LGE predicts failure to regain LVEF and higher decompensation rates 1
Muscular Dystrophies
- Early detection: LGE may be present when echocardiography remains normal 1
- Pattern: Mid-myocardial/subepicardial LGE, occasional non-compacted myocardium 1
- Monitoring: Strain imaging detects abnormalities before overt heart failure and tracks disease progression 1
- T1/ECV abnormalities: Associated with arrhythmia risk 1
Key MRI Sequences and Their Applications
Late Gadolinium Enhancement (LGE)
- Universal prognostic value: Regardless of etiology, extent of LGE predicts malignant arrhythmia and heart failure risk 1
- Pattern recognition: Different LGE distributions distinguish cardiomyopathy subtypes:
- Linear mid-myocardial: DCM
- Patchy mid-myocardial: Myocarditis, sarcoidosis
- Subepicardial: Myocarditis
- Subendocardial: Amyloidosis, ischemia
- Basal inferolateral: Anderson-Fabry disease 1
Parametric Mapping
- T1-mapping: Detects diffuse fibrosis, edema, and infiltration without contrast (useful in renal dysfunction) 1
- T2-mapping: Identifies inflammatory processes with high sensitivity 1
- T2-mapping*: Quantifies iron overload in hemochromatosis 1
- ECV quantification: Increased in multiple disorders; tracks therapeutic response more sensitively than LGE 1
Functional Imaging
- Cine sequences: Evaluate morphology (thickening, thinning, apical ballooning, trabeculations) and quantify function with high reproducibility 1
- Strain imaging: Detects early regional dysfunction before global systolic impairment 1, 2
- Stress perfusion: Excludes ischemia and detects microvascular dysfunction 1
Clinical Advantages Over Other Modalities
Superior to echocardiography for:
- Visualizing LV apex, lateral wall, basal septum, and entire RV 1
- Quantifying myocardial thickness accurately (critical for HCM surgical planning) 1
- Assessing non-compaction extent in all LV segments 1
- Detecting subtle structural changes in early disease 2
Complementary to cardiac CT:
- Higher contrast-to-noise ratio for tissue characterization 1
- No radiation exposure, allowing serial follow-up 1
- Superior temporal resolution for functional assessment 2
Important Clinical Caveats
Device compatibility: MRI can now be performed on most pacemakers/ICDs with technical adjustments and wide-band inversion recovery sequences to mitigate artifacts 1
Contrast considerations: Native T1-mapping enables tissue characterization without gadolinium in patients with renal dysfunction 1
Vendor variability: Use same vendor for serial surveillance when assessing strain parameters 2
LVNC overdiagnosis: Current MRI criteria have poor specificity (15-43% false positives in healthy individuals)—integrate clinical context 1
Endomyocardial biopsy guidance: MRI can direct biopsy to areas of active inflammation or fibrosis 1